Role of Serum CYFRA 21-1 in Diagnosis and Prognostic in Colorectal Liver Metastases

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Goodla L, Xue X. The role of inflammatory mediators in colorectal cancer hepatic metastasis. Cells. 2022;11(15):2313. doi:10.3390/cells11152313
   PubMed Web of Science ®Google Scholar
• Zeng X, Ward SE, Zhou J, Cheng ASL. Liver immune microenvironment and metastasis from colorectal cancer‐pathogenesis and therapeutic perspectives. Cancers. 2021;13(10):1–22. doi:10.3390/cancers13102418
   Web of Science ®Google Scholar
• Bie Y, Ge W, Yang Z, et al. The crucial role of CXCL8 and its receptors in colorectal liver metastasis. Dis Markers. 2019;2019:1–12. doi:10.1155/2019/8023460
   Web of Science ®Google Scholar
• Sun L, Guo C, Burnett J, Yang Z, Ran Y, Sun D. Serum carboxypeptidaseA4 levels predict liver metastasis in colorectal carcinoma. Oncotarget. 2016;7(48):78688–78697. doi:10.18632/oncotarget.12798
   PubMedGoogle Scholar
• Huang M, Cheng L, Mo SS, Ru H, Mo X, Yan L. Evaluation of colorectal cancer liver metastases based on liquid biopsy combined with folate receptor– positive circulating tumor cells and HSP90. Front Oncol. 2022;12:1–14. doi:10.3389/fonc.2022.912016
   Web of Science ®Google Scholar
• Yuan J, Sun Y, Wang K, et al. Development and validation of reassigned CEA, CYFRA21-1 and NSE-based models for lung cancer diagnosis and prognosis prediction. BMC Cancer. 2022;22(1):686. doi:10.1186/S12885-022-09728-5
   PubMed Web of Science ®Google Scholar
• Ji M, Zhang LJ. Expression levels of SCCA and CYFRA 21-1 in serum of patients with laryngeal squamous cell carcinoma and their correlation with tumorigenesis and progression. Clin Transl Oncol. 2021;23(2):289–295. doi:10.1007/S12094-020-02417-4
   PubMed Web of Science ®Google Scholar
• Qiao Y, Ma M, Zhang H, Yu Z, Tang P. Prognostic significance of the combination of fibrinogen and tumor marker index in esophageal squamous cell carcinoma patients. Onco Targets Ther. 2021;14:1101–1111. doi:10.2147/OTT.S278831
   PubMed Web of Science ®Google Scholar
• Lee JH. Clinical usefulness of serum CYFRA 21-1 in patients with colorectal cancer. Nucl Med Mol Imaging. 2013;47(3):181–187. doi:10.1007/S13139-013-0218-4
   PubMedGoogle Scholar
• Thomas DS, Fourkala EO, Apostolidou S, et al. Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples. Br J Cancer. 2015;113(2):268–274. doi:10.1038/bjc.2015.202
   PubMed Web of Science ®Google Scholar
• Wild N, Andres H, Rollinger W, et al. A combination of serum markers for the early detection of colorectal cancer. Clin Cancer Res. 2010;16(24):6111–6121. doi:10.1158/1078-0432.CCR-10-0119
   PubMed Web of Science ®Google Scholar
• Duffy MJ, Lamerz R, Haglund C, et al. Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Int J Cancer. 2014;134(11):2513–2522. doi:10.1002/ijc.28384
   PubMed Web of Science ®Google Scholar
• Li N, Lu B, Luo C, et al. Incidence, mortality, survival, risk factor and screening of colorectal cancer: a comparison among China, Europe, and Northern America. Cancer Lett. 2021;522:255–268. doi:10.1016/j.canlet.2021.09.034
   PubMed Web of Science ®Google Scholar
• Doll KM, Rademaker A, Sosa JA. Practical guide to surgical data sets: Surveillance, Epidemiology, and End Results (SEER) database. JAMA Surg. 2018;153(6):588–589. doi:10.1001/JAMASURG.2018.0501
   PubMed Web of Science ®Google Scholar
• Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409–436. doi:10.3322/CAAC.21731
   PubMed Web of Science ®Google Scholar
• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (Concord-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075. doi:10.1016/S0140-6736(17)33326-3
   PubMed Web of Science ®Google Scholar
• Fahrmann JF, Marsh T, Irajizad E, et al. Blood-based biomarker panel for personalized lung cancer risk assessment. J Clin Oncol. 2022;40(8):876–883. doi:10.1200/JCO.21.01460
   PubMed Web of Science ®Google Scholar
• Wang X, Wang M, Feng L, et al. Four-protein model for predicting prognostic risk of lung cancer. Front Med. 2022;16(4):618–626. doi:10.1007/S11684-021-0867-0
   PubMed Web of Science ®Google Scholar
• Yin L, Li Q, Mrdenovic S, et al. KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin/c-Myc signaling pathway. Breast Cancer Res. 2022;24(1):7. doi:10.1186/S13058-022-01502-6
   PubMed Web of Science ®Google Scholar
• Werner S, Keller L, Pantel K. Epithelial keratins: biology and implications as diagnostic markers for liquid biopsies. Mol Aspects Med. 2020;72:1. doi:10.1016/j.mam.2019.09.001
   Web of Science ®Google Scholar
• Shukla P, Dange P, Mohanty BS, Gadewal N, Chaudhari P, Sarin R. ARID2 suppression promotes tumor progression and upregulates cytokeratin 8, 18 and β-4 integrin expression in TP53-mutated tobacco-related oral cancer and has prognostic implications. Cancer Gene Ther. 2022;29(12):1908–1917. doi:10.1038/S41417-022-00505-X
   PubMed Web of Science ®Google Scholar
• Nowak E, Bednarek I. Aspects of the epigenetic regulation of EMT related to cancer metastasis. Cells. 2021;10(12):3435. doi:10.3390/CELLS10123435
   PubMed Web of Science ®Google Scholar
• Urano-Takaoka M, Sumida H, Miyagawa T, et al. Serum cytokeratin 18 as a metastatic and therapeutic marker for extramammary paget’s disease. Acta Derm Venereol. 2022;102:adv00636. doi:10.2340/ACTADV.V101.866
   PubMed Web of Science ®Google Scholar
• Lim DH, Lee JH, Kim JW. Feasibility of CYFRA 21-1 as a serum biomarker for the detection of colorectal adenoma and advanced colorectal adenoma in people over the age of 45. J Clin Lab Anal. 2018;32(1):e22163. doi:10.1002/JCLA.22163
   PubMed Web of Science ®Google Scholar
• Yu M, Yang C, Wang S, et al. Serum ProGRP as a novel biomarker of bone metastasis in prostate cancer. Clin Chim Acta. 2020;510:437–441. doi:10.1016/J.CCA.2020.08.007
   PubMed Web of Science ®Google Scholar
• Peng SJ, Wang CF, Yu YJ, et al. CYFRA21-1/TG ratio as an accurate risk factor to predict eye metastasis in nasopharyngeal carcinoma: a STROBE-compliant article. Medicine. 2020;99(46):e22773. doi:10.1097/MD.0000000000022773
   PubMed Web of Science ®Google Scholar
• Lin Q, Chen XY, Liu WF, et al. Diagnostic value of CA-153 and CYFRA 21-1 in predicting intraocular metastasis in patients with metastatic lung cancer. Cancer Med. 2020;9(4):1279–1286. doi:10.1002/CAM4.2354
   PubMed Web of Science ®Google Scholar
• Jiang C, Zhao M, Hou S, et al. The indicative value of serum tumor markers for metastasis and stage of non-small cell lung cancer. Cancers. 2022;14(20):5064. doi:10.3390/CANCERS14205064
   PubMed Web of Science ®Google Scholar
• Jeong C, Lee J, Yoon H, et al. Serum CYFRA 21.1 level predicts disease course in thyroid cancer with distant metastasis. Cancers. 2021;13(4):1–13. doi:10.3390/CANCERS13040811
   Web of Science ®Google Scholar
• Caviglia GP, Ciruolo M, Olivero A, et al. Prognostic role of serum cytokeratin-19 fragment (CYFRA 21-1) in patients with hepatocellular carcinoma. Cancers. 2020;12(10):1–10. doi:10.3390/cancers12102776
   Web of Science ®Google Scholar
• Li L, Liu G, Jin K, et al. Prognostic significance of pre-treatment serum Cyfra21-1 as a tumor marker in patients with oropharyngeal squamous cell carcinoma treated with concurrent chemoradiotherapy. Ann Transl Med. 2020;8(20):1302. doi:10.21037/ATM-20-6124
   PubMed Web of Science ®Google Scholar
• Pedraza S, Seiffert AP, Sarandeses P, et al. The value of metabolic parameters and textural analysis in predicting prognosis in locally advanced cervical cancer treated with chemoradiotherapy. Strahlenther Onkol. 2022;198(9):792–801. doi:10.1007/S00066-022-01900-X
   PubMed Web of Science ®Google Scholar
• Ju M, Ge X, Di X, Zhang Y, Liang L, Shi Y. Diagnostic, prognostic, and recurrence monitoring value of plasma CYFRA21-1 and NSE levels in patients with esophageal squamous cell carcinoma. Front Oncol. 2022;11:789312. doi:10.3389/FONC.2021.789312/PDF
   PubMed Web of Science ®Google Scholar
• Nakata B, Chung YS, Kato Y, et al. Clinical significance of serum CYFRA 21-1 in gastric cancer. Br J Cancer. 1996;73(12):1529–1532. doi:10.1038/BJC.1996.288
   PubMed Web of Science ®Google Scholar
• Holdenrieder S, Stieber P, Liska V, et al. Cytokeratin serum biomarkers in patients with colorectal cancer. Anticancer Res. 2012;32(5):1971–1976.
   PubMed Web of Science ®Google Scholar
• Menclová K, Pudil J, Benešová L, et al. Circulating tumor DNA as a biomarker in metastatic colorectal carcinoma case report. Rozhl Chir. 2020;99(4):179–182. doi:10.33699/PIS.2020.99.4.179-182
   PubMedGoogle Scholar
• Tang M, Wang H, Cao Y, Zeng Z, Shan X, Wang L. Nomogram for predicting occurrence and prognosis of liver metastasis in colorectal cancer: a population-based study. Int J Colorectal Dis. 2021;36(2):271–282. doi:10.1007/s00384-020-03722-8
   PubMed Web of Science ®Google Scholar